Although experimental evidence could not be found suggesting a relationship between p53 and PGC-1α, soft tissue sarcomas (STS) with mutant p53 overexpress MDR-1 and maintain multi-drug resistance [82]. The gene discussed is TP53; the disease is soft tissue sarcoma.